Related video above: Doctor explains: Effectiveness of COVID treatments, prevention measuresTocilizumab, a repurposed rheumatoid arthritis drug once considered a promising treatment for hospitalized patients with COVID-19, generally did not increase patients’ chances of survival or help them get better faster, according to three trials published this week.However, a fourth trial did find the drug increased the chances of survival, but because it was an observational